High levels of soluble CD25 in COVID‐19 severity suggest a divergence between anti‐viral and pro‐inflammatory T‐cell responses

Author:

Xie Min12,Yunis Joseph3,Yao Yin34,Shi Jing12,Yang Yang35,Zhou Pengcheng36ORCID,Liang Kaili7,Wan Yanmin89,Mehdi Ahmed3,Chen Zhian3,Wang Naiqi3,Xu Shuyun12,Zhou Min12,Yu Muqing12,Wang Ke12,Tao Yu12,Zhou Ying12,Li Xiaochen12,Liu Xiansheng12,Yu Xiao10,Wei Yunbo5,Liu Zheng4,Sprent Jonathan1112,Yu Di3567ORCID

Affiliation:

1. Department of Respiratory and Critical Care Medicine Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

2. Key Laboratory of Respiratory Diseases National Ministry of Health of the People's Republic of China National Clinical Research Center for Respiratory Disease Wuhan China

3. The University of Queensland Diamantina Institute Faculty of Medicine The University of Queensland Brisbane QLD Australia

4. Department of Otolaryngology‐Head and Neck Surgery Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

5. Shandong Artificial Intelligence Institute Qilu University of Technology (Shandong Academy of Sciences) Jinan China

6. Department of Immunology and Infectious Disease John Curtin School of Medical Research Australian National University Canberra ACT Australia

7. China–Australia Centre for Personalised Immunology Shanghai Renji Hospital Shanghai Jiaotong University School of Medicine Shanghai

8. Department of Infectious Diseases Huashan Hospital Fudan University Shanghai China

9. Department of Radiology Shanghai Public Health Clinical Center Fudan University Shanghai China

10. Department of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

11. Immunology Division Garvan Institute of Medical Research Darlinghurst NSW Australia

12. St Vincent’s Clinical School University of New South Wales Sydney NSW Australia

Funder

National Health and Medical Research Council

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3